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The regulator of citrate metabolism, CitO, from Enterococcus faecalis belongs to the
FCD family within the GntR superfamily. In the presence of citrate, CitO binds to
cis-acting sequences located upstream of the cit promoters inducing the expression of
genes involved in citrate utilization. The quantification of the molecular binding affinities,
performed by isothermal titration calorimetry (ITC), indicated that CitO has a high affinity
for citrate (K =D 1.2 ± 0.2µM), while it did not recognize other metabolic intermediates.
Based on a structural model of CitO where a putative small molecule and a metal binding
site were identified, it was hypothesized that the metal ion is required for citrate binding.
In agreement with this model, citrate binding to CitO sharply decreased when the protein
was incubated with EDTA. This effect was reverted by the addition of Ni2+, and Zn2+
to a lesser extent. Structure-based site-directed mutagenesis was conducted and it
was found that changes to alanine in residues Arg97 and His191 resulted in decreased
binding affinities for citrate, as determined by EMSA and ITC. Further assays using lacZ
fusions confirmed that these residues in CitO are involved in sensing citrate in vivo.
These results indicate that the molecular modifications induced by a ligand and a metal
binding in the C-terminal domain of CitO are required for optimal DNA binding activity,
and consequently, transcriptional activation.
Keywords: Enterococcus, metalloprotein, citrate, FadR family, FCD domain
INTRODUCTION
Members of the GntR superfamily of transcription factors, Pfam PF00392 (Bateman et al., 2002),
are found in diverse bacterial genomes. This group of proteins was first described in 1991 and
named after the gluconate operon repressor in Bacillus subtilis (Haydon and Guest, 1991). GntR-
like regulators are known to control many fundamental cellular processes, such as motility (Jaques
and Mccarter, 2006), development (Hoskisson et al., 2006), antibiotic production (Ostash et al.,
2011), antibiotic resistance (Truong-Bolduc and Hooper, 2007), plasmid transfer (Reuther et al.,
2006), and virulence (Casali et al., 2006). However, most of the specific small molecules that act as
a signal to regulate the expression of the respective genes are unknown.
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The canonical scaffold of the GntR superfamily consist of
a DNA-binding winged helix–turn–helix topology (HTH motif,
followed by a β-hairpin) in the N-terminus of the protein.
The effector-binding domain, which also functions as the
oligomerization domain, is usually located at the C-terminus of
the protein. Upon binding of an effector molecule at the C-
terminal domain, a conformational change occurs in the protein
affecting the DNA-binding properties of the regulator. These
conformational changes will result in repression or activation
of gene transcription (Van Aalten et al., 2001). The C-terminal
regulatory ligand binding domain differs significantly among
individual proteins and is currently used to classify members
of this superfamily into six major families: HutC, MocR, YtrA,
AraR, PlmA, and FCD (FadR C-terminal Domain; Rigali et al.,
2002; Lee et al., 2003; Franco et al., 2006; Zheng et al., 2009).
Although the tertiary structures of several members of these
large families are well described and publically available, the
information on their sensory ligands and ligand binding pockets
is very scarce. The FCD family clusters more than 40% of all
GntRmembers, with FadR from E. coli, the regulator for fatty acid
biosynthesis and degradation, being one of the best characterized
(Van Aalten et al., 2000, 2001).
CitO, a member of the FCD Family, is the transcription
factor required for the expression of the genes involved in
citrate metabolism in Enterococcus faecalis. The cit cluster is
encoded in two divergent operons: citHO encoding for the
citrate transporter citH, and the regulatory protein citO. The
catabolic enzymes are encoded upstream, in the minus strand,
in the oadHDB-citCDEFX-oadA-citMG operon (Blancato et al.,
2006, 2008; Espariz et al., 2011; Repizo et al., 2013). There are
two binding elements for CitO in the intergenic region, which
regulate the expression of genes involved in the transport and
degradation of citrate. In presence of citrate, CitO binds to
the cis-acting sequences located in the cit intergenic region.
In the citHO operon coding strand, CitO protects the region
between positions −41 and −65 (binding site O1); whereas
in the oadHDB-citCDEFX-oadA-citMG operon, CitO protects
the region between positions −51 and −74 (binding site O2;
Figure 1A). We previously showed that the interaction with
citrate increased the binding of CitO to the DNA, and that the
CitO/citrate complex had higher affinity for the O1 than the
O2 binding site. Interestingly, in vivo and in vitro experiments
suggest that CitO is specifically activated only by citrate and not
by other metabolic intermediates, such as malate, succinate, or
even by its isomer, isocitrate (Blancato et al., 2008). However, the
molecular mechanisms of such specificity were not investigated.
In the present study, we report the analysis of the binding
affinities of E. faecalis CitO for citrate. The binding pocket in
CitO was analyzed by site-directed mutagenesis and the critical
amino acids involved in the ligand binding were identified.
Furthermore, we found that binding of a divalent cations, Ni2+,
or Zn2+ in the C-terminus of the protein improved CitO-citrate
interactions.
Abbreviations: EMSA, Electrophoretic mobility shift assays; DSF, Differential
scanning fluorimetry; ITC, Isothermal Titration Calorimetry; Tm, melting
temperature; IPC-AES, inductively coupled plasma atomic emission spectrometry.
MATERIALS AND METHODS
Bacterial Strains and Growth Conditions
The bacterial strains and plasmids used in this study are listed
in Table 1. E. coli strains were grown at 37◦C under aerobic
conditions in Luria-Bertani medium (LB) (Difco), or on LB
agar plates. E. coli DH5α (Invitrogen, Carlslab, CA) was used
to propagate the plasmids for protein purification and site-
directed mutagenesis. E. coli strain BL21(DE3)-Star (Novagen,
Gibbstown, NJ) was used to express CitO. When required,
the medium was supplemented with ampicillin (100µg/ml)
or kanamycin (50µg/ml). All antibiotics and chemicals were
purchased from Sigma-Aldrich (St. Louis, MO).
E. faecalis strains were routinely grown at 37◦C without
shaking in 100ml sealed bottles filled with 20–50ml of LB
medium containing 0.5% w/v glucose. Erythromycin (5µg/ml),
kanamycin (1000µg/ml), or chloramphenicol (10µg/ml) were
added when appropriate.
DNA Manipulations and Gene Cloning
Standard methods were used for chromosomal DNA isolation,
restriction enzyme digestion, agarose gel electrophoresis,
ligation, and transformation (Sambrook and Russell, 2001).
Plasmids were isolated using spin miniprep kits (Qiagen,
Valencia, CA) and PCR products were purified using
QIAquick purification kits (Qiagen). All the primers used
for this study are described in Table 2. The plasmids for
protein purification, protein expression in E. faecalis, and
transcriptional fusions are previously described in Blancato et al.
(2008).
Site-directed mutagenesis was performed using the
QuikChange Site-directed Mutagenesis kit (Stratagene)
according to the manufacturer’s protocol. Plasmids pET-
citO or pCitO were used as the templates. All the selected amino
acids were changed to alanine. The mutations were verified by
DNA sequencing using T7 universal primers.
Protein Purification
The His-tagged proteins in pET-citO were overexpressed in
E. coli BL21-Star(DE3) (Novagen). The cells were grown in
LB broth at 37◦C to an OD600 = 0.6. Gene expression was
induced with 0.4mM isopropyl 1-thio-β-D-galactopyranoside
(IPTG) and the cells were further incubated at 17◦C for 16 h.
The cells were then collected by centrifugation and stored
at−80◦C. For protein purification, the cells were resuspended
in binding buffer (500mM NaCl, 5% glycerol, 50mM Tris
pH 8.0, and 5mM imidazole) with 1mM phenylmethylsulfonyl
fluoride and disrupted using a French pressure cell press. The
lysates were clarified by centrifugation (30min at 17,000 g)
and applied to a metal chelate affinity column charged with
Ni2+. The column was washed (in binding buffer with 15mM
imidazole) and the proteins were eluted from the column
in elution buffer (binding buffer with 250mM imidazole).
The purified proteins were dialyzed against 10mM Tris (pH
8.0), 500mM NaCl, and 2.5% glycerol; aliquots were kept
at−80◦C.
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FIGURE 1 | Graphical representation of the citrate cluster and the domain organization in CitO and its predicted ligand binding pockets. (A) Schematic
representation of cit operons. PcitHO and PcitCL indicate promoter regions, +1 transcriptional start site, black rectangles indicate −10 and −35 boxes, O1 and O2
CitO binding sites. (B) The location of the amino acids selected in CitO for site-directed mutagenesis is indicated. (C) Close view of the residues in CitO predicted to
mediate interactions with citrate and Ni2+. CitO in silico modeling (blue) was performed using the structure of TM0439 from Thermotoga maritima (PDB 3FMS, Zheng
et al., 2009, cyan) as the template. In a stick representation (orange) are shown the acetate molecules, while as a green sphere is shown the Ni2+ found in TM0439
structure. The model was visualized and analyzed using PyMol.
Electrophoretic Mobility Shift Assays
EMSA analysis of CitO was performed using proteins purified
according to the procedures described above. A fragment
of 246 bp containing CitO binding sites (Blancato et al.,
2008) was generated by PCR using biotin labeled (5′-end)
primers (Table 2) and subsequently purified using QIAquick
spin columns (Qiagen). The optimized mix for EMSA (20µl)
contained 1 ng of a 5′-labeled DNA fragment, 10mM Tris-
HCl (pH 7.5), 150mM KCl, 0.5mM EDTA, 0.2mM DTT, 0.1%
Triton X-100, 12.5% glycerol, 25 ng/µl Poly(dI-dC) nonspecific
competitor DNA, and where indicated, purified CitO protein
(0–400 nM) or citrate (0–5mM). After incubation for 15min at
37◦C samples were separated on 5% acrylamide/bis-acrylamide
non-denaturing gels, in 0.5X Tris borate-EDTA buffer, with a pH
7.5 (TBE). Electrophoresis was performed at 4◦C. The DNA was
then transferred from the polyacrylamide gel to an Amersham
Hybond-N+Membrane (Ge Healthcare, USA) by electroblotting
at 250mA for 45min in a semidry transfer (Fisher Scientific,
Pittsburgh, PA, USA). Transferred DNA was UV-crosslinked
and biotin labeled DNA was detected using a Phototope-Star
Detection kit (NEB). Membranes were exposed to Kodak X-ray
film.
Size Exclusion Chromatography
Size exclusion chromatography was performed using 200µl
protein samples. Aliquots contained 28.4µM CitO, and where
indicated, 1mM citrate (pH 8.0). Following 30min of incubation
on ice, samples were injected onto a prepacked Superdex 75 (GE
Healthcare, Sweden) gel filtration column connected to a LCC-
501 plus (Pharmacia Biotech Inc., Piscataway, NJ) equilibrated
with 50mM Tris (pH 7.6), 300mM NaCl, and 5% glycerol.
Filtration was carried out at 4◦C, using a flow rate of 0.5ml/min.
The eluted proteins were monitored continuously for absorbance
at 280 nm using a UV-M II monitor (Pharmacia Biotech Inc.).
Blue dextran 2000 was used to determine the void volume of the
column. A mixture of protein molecular weight standards from
Bio-Rad containing bovine serum albumin (66 kDa), albumin
(45 kDa), lactalbumin (14.2 kDa), cytochrome C (12.7 kDa), and
vitamin B12 (1.35 kDa) were also applied to the column under
similar conditions. The elution volume and molecular mass of
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TABLE 1 | Bacterial strains, and plasmids used in this study.
Strain, or plasmid Genotype, or description Reference, or source
E. coli
DH5α F− φ80d/lacZ1M15 1(lacZYA-argF ) U169 recA1 endA1 hsdR17 (r−K , m
+
K ) phoA supE44 λ- thi- 1 gyrA96 relA1 Invitrogen
BL21-Star (DE3) F− ompT hsdSB(r−B m
−
B ) gal dcm rne131 (DE3); Str
r Novagen
E. faecalis
JH2-2 (TX4000) Plasmid-free wild-type strain; Fusr Rifr Jacob and Hobbs, 1974
JHB1 JH2-2 citO::pmCitO; Emr Blancato et al., 2008
JHB14 JHB1 carrying pTCV- PcitCL; Emr, Kmr Blancato et al., 2008
JHB14-02 JHB14 carrying pBM02; Emr, Cmr, Kmr This work
JHB14-wt JHB14 carrying pCitO; Emr, Cmr, Kmr This work
JHB14-64 JHB14 carrying pCitOQ64A; Emr, Cmr, Kmr This work
JHB14-74 JHB14 carrying pCitOH74A; Emr, Cmr, Kmr This work
JHB14-97 JHB14 carrying pCitOR97A; Emr, Cmr, Kmr This work
JHB14-143 JHB14 carrying pCitOF143A; Emr, Cmr, Kmr This work
JHB14-191 JHB14 carrying pCitOH191A; Emr, Cmr, Kmr This work
JHB14-214 JHB14 carrying pCitOL214A; Emr, Cmr, Kmr This work
PLASMIDS
pET-28a Expression vector for protein purification; Kmr Novagen
pBM02 Shuttle vector for gene expression in LAB; Ampr, Cmr Marelli and Magni, 2010
pTCV-lac Promoterless vector which allows lacZ fusion construction; Kmr Poyart and Trieu-Cuot, 1997
pET-citO pET28a derivative expressing His6-CitO Blancato et al., 2008
pCitO pBM02 derivative for expressing citO in E. faecalis Blancato et al., 2008
pTCV-PcitCL pTCV-lac carrying citCL promoter Blancato et al., 2008
pET-citOQ64A pET-citO with CitO Q64→ A This work
pET-citOH74A pET-citO with CitO H74→ A This work
pET-citOR97A pET-citO with CitO R97→ A This work
pET-citOF143A pET-citO with CitO F143→ A This work
pET-citOH191A pET-citO with CitO H191→ A This work
pET-citOL214A pET-citO with CitO L214→ A This work
pCitOQ64A pCitO with CitO Q64→ A This work
pCitOH74A pCitO with CitO H74→ A This work
pCitOR97A pCitO with CitO R97→ A This work
pCitOF143A pCitO with CitO F143→ A This work
pCitOH191A pCitO with CitO H191→ A This work
pCitOL214A pCitO with CitO L214→ A This work
Ampr , Kmr , Emr , Cmr , Fusr , Rif r , and Str r indicate resistant to ampicillin, kanamycin, erythromycin, chloramphenicol, fusidic acid, rifampicin, and streptomycin, respectively.
each protein standard was then used to generate a standard
curve from which the molecular weight of eluted proteins was
determined.
Analysis of CitO Associated Metals
Metal-content was determined using inductively coupled plasma
atomic emission spectrometry (ICP/AES) at the IFAS Analytical
Research Laboratory, University of Florida, Gainesville.
Differential Scanning Fluorimetry
The assay was carried out as described earlier (Pagliai et al.,
2010). Briefly, CitO (10µM), in presence or absence of increasing
concentrations of citrate or malate (the latter was used as
a negative control), was placed (in duplicate) into 96-well
plates (Bio-Rad, Hercules, CA) and heated from 25 to 80◦C
at the rate of 1◦C per min. The unfolding of the protein was
monitored by the increase in fluorescence of the fluorophore
SYPRO Orange (Invitrogen). Fluorescence intensities were
plotted against temperature for each sample well and transition
curves were fitted with the Boltzmann equation using Origin 8
software (Northampton, MA). The midpoint of each transition
curve was calculated and values obtained in presence of the ligand
compared to those calculated for CitO in absence of the ligand.
Isothermal Titration Calorimetry
Measurements were performed on a VP-Microcalorimeter
(MicroCal, Northampton, MA) at 25◦C. The proteins were
thoroughly dialyzed against 10mM Tris (pH 8.0), 500mM
NaCl, and 2.5% glycerol. A solution of citrate (1mM, pH 8.0)
was directly prepared in dialysis buffer. Each titration involved
a series of 3µl injections of the effector molecule into the
protein solution. The mean enthalpies measured from injection
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TABLE 2 | Oligonucleotides used in this study.
Primer Sequence (5′→3′)
EMSA PROBE
CitOE-F GTGTGAGAATATACAAACTTTCGCAG
CitOE-R GGTATACGTTCATTATAGAAAAAACCG
SITE DIRECTED MUTAGENESIS
CitOQ64A-F GACGCCCATTCGCTTTGCTTTAGCAGAATTGGTCAAAGAACAATTG
CitOQ64A-R CAATTGTTCTTTGACCAATTCTGCTAAAGCAAAGCGAATGGGCGTC
CitOH74A-F GTCAAAGAACAATTGGTGGAAGCTATACCTATGGTGGGTATCGTG
CitOH74A-R CACGATACCCACCATAGGTATAGCTTCCACCAATTGTTCTTTGAC
CitOR97A-F GCTTATGAAATTTATGATATTGCTAAATCTTTGGACACTTTAGC
CitOR97A-R GCTAAAGTGTCCAAAGATTTAGCAATATCATAAATTTCATAAGC
CitOF143A-F GTAGATGACTTACTACAGAACGCTTCAGATTTTAATTCCTTTATTTATAC
CitOF143A-R GTATAAATAAAGGAATTAAAATCTGAAGCGTTCTGTAGTAAGTCATCTAC
CitOH191A-F CGTAGTATTGCCCTAGAAGAAGCTTGGTTAATTTTCCGCG
CitOH191A-R CGCGGAAAATTAACCAAGCTTCTTCTAGGGCAATACTACG
CitOL214A-F CACTTTTAACCCATGAACATGCAAATCGTTCGCTTCAATTTATTTTG
CitOL214A-R CAAAATAAATTGAAGCGAACGATTTGCATGTTCATGGGTTAAAAGTG
of the ligand in the buffer were subtracted from raw titration
data prior to data analysis with Origin 8 software (MicroCal).
Titration curves were fitted by a nonlinear least squares method
to a function for the binding of a ligand to a macromolecule
(Wiseman et al., 1989). From the curve thus fitted, the parameters
1H (reaction enthalpy), KA (binding constant, KA = 1/KD), and
N (reaction stoichiometry) were determined. From the values of
KA and 1H, the changes in free energy (1G) and entropy (1S)
were calculated with the following equation: 1G=−RT lnKA =
1H−T1S; where R is the universal molar gas constant and T is
the absolute temperature.
Structure Modeling and Analysis
Phyre2 (http://www.sbg.bio.ic.ac.uk/phyre2/html/page.cgi?id=
index; Kelley et al., 2015) was used to model the tridimensional
structure of CitO. PDB entries 3FMS and 3C7J were retrieved
as the highest scoring templates. PDB 3FMS corresponds to
the protein TM0439, a putative transcriptional regulator from
Thermotoga maritima (Zheng et al., 2009), while PDB 3C7J
corresponds to a transcriptional regulator from Pseudomonas
syringae pv. tomato str. DC3000. The structural models were
visualized using the PyMOL molecular graphics system v1.3
(http://www.pymol.org/, Schrödinger, LLC).
β-Galactosidase Assays
Overnight cultures of E. faecalis cells transformed with a reporter
plasmid and/or a control plasmid grown in LB glucose containing
containing kanamycin, erythromycin, and chloramphenicol were
diluted to anOD600 = 0.08 and subsequently cultured in fresh LB
medium supplemented with or without 17mM citrate. At early
stationary phase (OD600 = 0.8), the cells were permeabilized
with 0.15% sodium dodecyl sulfate (SDS) and 1.5% chloroform
in Z-buffer (60mM Na2HPO4, 40mM NaH2PO4, 10mM KCl,
1mM MgSO4, 50mM β-mercapthoethanol). β-galactosidase
activity was colorimetrically determined using ONPG as a
substrate at 420 nm. The activity was quantified as described by
Miller (1972), and subsequently normalized to the CitO protein
concentration determined by western blot, and expressed as
arbitrary units (AU). The assays were performed in triplicate. The
reporter plasmid, pTCV-PcitCL (Table 1) (Blancato et al., 2008),
was used to determine PcitCL promoter activity. The basal AU
was determined from assays performed with the empty plasmids
(pBM02 and pTCV-lac, Table 1).
Western Blot Analysis
E. faecalis strains were grown at 37◦C for 6 h in LB medium
in the presence or absence of 17mM citrate. Cells were
harvested by centrifugation and the cell free extracts were
prepared by vortexing cells with glass beads (425–600 microns,
Sigma-Aldrich). Proteins were separated by sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) on a 12%
polyacrylamide gel, and transferred to a nitrocellulose membrane
by electroblotting. Proteins were detected using primary antibody
rabbit polyclonal antisera against CitO of E. faecalis. Antibodies
were visualized by using a secondary anti-rabbit antibody
coupled to alkaline phosphatase (Bio-Rad).
RESULTS
Functional Analysis of the CitO Ligand
Binding Pocket
We previously established that CitO induced the expression of
the cit operons by specifically binding citrate (Blancato et al.,
2008). To determine the citrate binding site, a structural model
of E. faecalis CitO was constructed using Phyre2. The structure
of TM0439 from T. maritima (PDB 3FMS, Zheng et al., 2009)
was retrieved as the highest scoring template (Figure 1). The
obtained model had a 90% of coverage, a QMEAN Z-score
of −2.97 (Benkert et al., 2011), and 19% identity with TM0439
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(Supplementary Figure S1). The structure of TM0439 was solved
with two molecules of acetate; one localized in the N-terminus
and the second in the C-terminus next to a Ni2+ atom. We
performed a structural alignment between CitO and TM0439,
with the associated acetate molecules used as an indication of
the potential binding pocket for citrate in CitO. Although the
C-terminus is associated with the binding of effector molecules,
the binding site located in the HTH domain was not discarded in
our studies. To determine which pocket is the biologically active
site, the relevant residues surrounding the acetate molecules were
selected for further analyses (Figures 1B,C). In the HTH domain,
amino acids Q64 and H74 were selected. In the C-terminal
domain, six residues within 3 Å to the acetate molecule were
identified (R97, F143, N147, H191, H213, and L214). Specifically,
residues N147, H191, and H213 were located in the proximity
of the acetate molecule and in close distance to a Ni2+ atom
associated with the protein. Based on these observations, we
hypothesized that a cation may facilitate the binding of the ligand
to the protein or be involved in shaping the binding groove. The
residues Q64, H74, R97, F143, H191, and L214 were mutated to
alanine and the proteins were subsequently purified. The effect
of each individual mutation was then evaluated based on their
ability to bind DNA and/or citrate, and their biological relevance
was validated in vivo.
The ability of CitO or its mutant variants to bind DNA
was determined using a 246 bp fragment (PcitH−CL) containing
the promoter region of the citHO operon (PcitH) and the citCL
operon (PcitCL) harboring both the O1 and O2 binding sites
(Figure 1A). It was observed that the binding of CitO wild type
protein (CitO-wt) to this region resulted in multiple unstable
complexes. The stability of the CitO-DNA complexes increased
with CitO concentrations (up to 400 nM) and with the addition
of citrate (up to 5mM) to the binding reaction (Figure 2).
Although several binding buffers were tested, a defined band for
the protein-DNA complex was not obtained.
Once the binding conditions for CitO-wt were optimized,
the ability of mutants in CitO to bind DNA was evaluated. The
results obtained with EMSA (Figure 2) allowed the classification
of mutations in four groups: group I showed no effect on DNA or
citrate binding (Q64A). Group II showed both a decrease in DNA
binding and less response to citrate (H74A, R97A, and H191A).
Group III showed a decrease in DNA binding but was able to
increase DNA binding in the presence of citrate (L214A). Group
IV showed DNA binding comparable to CitO-wt in absence of
citrate, but it had a dramatic increase in DNA binding when
citrate was added to the reaction mix (F143A).
The mutation Q64A (located in the DNA binding domain)
showed a similar DNA and ligand binding pattern compared
to CitO-wt. CitO-Q64A showed some DNA binding at 200 nM
protein. In presence of citrate, the ability of this protein to bind
the DNA probe used was comparable to the wild type. These
results suggest that Q64 is not critically involved in DNA or
citrate binding.
The mutations on H74A (located in the DNA binding
domain), R97A, and H191A (located in the C-terminal domain)
severely affected the DNA binding. With CitO-H74A, a faint
protein:DNA complex was observed only after 200 nM protein
was used. Meanwhile, with the proteins carrying the mutations
R97A or H191A, the complex was detectable at the lowest
concentration of protein used (100 nM). The addition of citrate
FIGURE 2 | Alanine substitution on the HTH or C-terminal domains of CitO decrease binding to PcitH−CL. EMSA were performed using biotin-labeled
PcitH−CL (1 ng) and increasing concentrations of CitO-wt or CitO mutants (0.1, 0.2, 0.4µM), in the presence or absence of citrate (5mM) as indicated on top of each
panel. No protein was added to the first lane.
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did not modify the formation of protein:DNA complexes when
compared with CitO-wt (Figure 2). These results indicate that
H74, R97, and H191 amino acids could be involved in the
interaction with DNA, citrate, or both.
The L214A mutation (located in the C-terminal domain)
showed decreased DNA binding compared to CitO-wt. The
addition of citrate increased the binding of CitO-L214A to
PcitH−CL to a level similar to CitO-wt (Figure 2).
CitO-F143A, a mutation located in the C-terminal domain,
showed a similar DNA binding pattern to CitO-wt in absence of
citrate. Surprisingly, in presence of 5mM citrate a strong shift in
the CitO-F143A was observed, suggesting higher affinity of the
protein for the ligand (Figure 2).
Mutations in the C-Terminal of CitO Modify
its Thermal Stability in the Presence and in
the Absence of Citrate
Gel shift assays indicated that specific amino acid substitutions
affected the ability of CitO to bind DNA, as well as the binding
of the effector molecule citrate. To identify the residues involved
only in citrate binding, differential scanning fluorimetry (DSF)
followed by isothermal titration calorimetry (ITC) analyses were
performed.
DSF was carried out by monitoring the increment in
fluorescence of SYPRO orange due to protein unfolding. The
proteins were subjected to DSF in presence and absence of
ligands. CitO-wt showed two apparent melting temperatures
(Tm) in DSF analyses (Figure 3): Tm1 = 43◦C and Tm2 =
58◦C. This effect may result from the sequential unfolding of
the different protein domains or changes in oligomerization of
the protein (Niesen et al., 2007; Gupta and Grove, 2014). The
predicted molecular weight of the CitO monomer is 27 kDa.
Size-exclusion chromatography analysis indicated that CitO has
an apparent molecular weight of 48 kDa in solution, consistent
with the predictedmolecular weight of the dimer (Supplementary
Figure S2). The addition of citrate did not modify the
oligomerization state of CitO in solution. Altogether, these
data indicate that different transition temperatures observed for
CitO-wt may be the result of the subsequent and independent
unfolding of DNA and ligand-binding domains. In agreement
with this observation, the addition of citrate to CitO-wt induced
a shift in the Tm2 but not on Tm1, indicative of increased protein
stability upon ligand binding (Figure 3). The specificity of this
interaction was determined by adding other small carboxylic
acids, such us malate, succinate, or isocitrate. As expected, CitO
did not show a shift in the Tm2 in presence of other small
molecules. Since changes in Tm2 were associated with citrate
binding to CitO, this parameter was analyzed in all the CitO
mutants.
CitO-Q64A melting profile was similar to CitO-wt, the
addition of 5µM citrate resulted in a clear shift in Tm, while at
50µM a higher stability was observed. Interestingly, the CitO-
H74A mutant showed a melting profile similar to CitO-Q64A
and it was comparable to the wild type. These results indicate that
CitO-H74A is still able to interact with citrate in solution. Since
FIGURE 3 | Mutations in the C-terminal of CitO modify its thermal stability in the presence and in the absence of citrate. DSF was performed with purified
CitO-wt and its mutant variants (indicated on top of each figure) in the absence or presence of increasing concentrations of citrate (1, 5, 50, 100, or 1000µM). Purified
proteins (20µM) were subjected to gradually increasing temperatures in the presence of SYPRO Orange fluorophore. Fluorescence intensities were plotted against
temperature and transition curves were fitted using the Boltzmann equation.
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CitO-H74A binds DNA with low affinity, we hypothesized that
this residue is involved in direct binding to DNA and/or in signal
transduction from the C-terminal domain to N-terminal domain.
CitO-R97A and CitO-H191A also showed poor DNA and
citrate binding on EMSA (Figure 2). DSF assays showed that in
the presence or absence of citrate the protein denatured at similar
temperature, even at high citrate concentrations (1mM). These
results suggest that CitO-R97 and CitO-H191 are most likely,
directly involved in citrate binding.
The CitO-L214A mutant showed an increase in Tm2
(1Tm= 4◦C) only when 50µMcitrate (or higher) was present in
the mixture. The CitO-F143Amutant also showed one transition
curve with a Tm = 50◦C. In agreement with the results obtained
in EMSA, the addition of 50µM citrate induced a strong shift in
the Tm (Tm = 57◦C). These results suggest stronger binding of
the effector molecule in the binding pocket of the regulator.
To further characterize the interactions of CitO and its
mutated variants with the effector molecule, the thermodynamic
properties of CitO interactions with citrate were determined
using ITC. The titration of CitO with citrate followed an
endothermal heat change profile, giving rise to a sigmoidal
binding curve (Figure 4). The data were fitted with the Origin
software using the “one set of sites model.” The estimated
thermodynamic parameters are summarized in Table 3. CitO-wt
dissociation constant (KD) with citrate was in the lowmicromolar
range (KD = 1.2 ± 0.2µM) indicating a high affinity for the
ligand. Interestingly, the affinity for citrate increased in the CitO-
F143A mutant as evidenced by lower KD values (Table 3). The
1H was positive indicating an entropically driven reaction and
FIGURE 4 | Isothermal titration calorimetric data for the binding of
citrate to CitO. Heat changes (upper panel) and integrated peak areas (lower
panel) for the injection of a series of aliquots (3µl) of 1mM ligand in a solution
of 28µM CitO. Experiments were carried out at 25◦C.
the enthalpy variations were similar in the wt and all of the
mutants (∼6000 cal/mol) with the exception of CitO-F143A,
which showed a 1H = 16020 cal/mol. In agreement with DSF
assays, CitO-R97A and CitO-H191A mutants did not interact
with citrate.
The stoichiometry of the reaction was N = 0.4. Considering
that CitO is a dimer in solution, these results suggest either the
binding of one citrate molecule per dimer or that a fraction of the
purified protein may contain citrate bound picked up during the
heterologous expression in E. coli [citrate concentration in E. coli
ranges 2–30mM depending on growth conditions (Bennett et al.,
2009)].
Citrate- CitO Interactions are Mediated by
a Metal Cofactor
TM0439 has three histidines (His134, His174, and His196) in its
C-terminal domain, with imidazole groups arranged in a three-
blade propeller scaffold. This arrangement is usually associated
with the binding of metal groups like Zn2+ or Ni2+ with high
affinity. In agreement with this observation, TM0439 is able
to bind these ions with KD values in the nanomolar range
(Zheng et al., 2009). Based on the structural model, the CitO
residues potentially involved in metal (Me2+) binding were
Asn147, His191, and His213. IPC-AES analysis was performed
to determine if a metal atom was found in CitO-wt, or some
mutant variants with different responses to citrate. It was found
that CitO-wt, CitO-R97A, and CitO-F143A contained 1.02, 1.1,
and 1.06 atoms of Ni2+ per molecule of protein, respectively.
In contrast, in the mutant CitO-H191A, the amount of metal
decreased to 0.59 Ni2+ per molecule of protein. These results
indicate that H191 is likely involved in metal interaction. Trace
amounts of Zn2+ (0.05–0.07 Zn2+ per molecule of protein) were
also found in all the tested proteins.
The change of H191 to Ala caused a strong effect on the ability
of CitO to bind DNA and interact with citrate. These results may
be explained by the reduced ability of the CitO-H191Amutant to
bind Me2+. To test this hypothesis, the DNA binding ability of
CitO to PcitH−CL, supplemented with different divalent cations,
was evaluated. It was found that the addition of Ca2+, Mn2+, or
Mg2+ did notmodify the binding of CitO to PcitH−CL, while Zn2+
and Ni2+ decreased the binding (Figure 5A). In the presence of
citrate, none of the Me2+ affected the binding of CitO to PcitH−CL
(Figure 5B).
To test the role ofMe2+ in citrate binding, CitO was incubated
in presence of 100mM EDTA. It was found that the depletion of
Me2+ decreased the binding of CitO to PcitH−CL; however, just
the addition of metals did not rescue the phenotype observed
(Figure 5C). Moreover, it was found that the addition of citrate
alone improved the formation of intermediate complexes, while
the supplementation with citrate and Ni2+ or Zn2+ increased
the stability of the larger CitO-PcitH−CL complexes (Figure 5D).
These results indicate that citrate binding to CitO is mediated by
a metal cofactor, and that these interactions are required for CitO
binding to PcitH−CL.
These results were confirmed by testing the mutants CitO-
R97A, which is irresponsive to citrate but it is still able to bind
metal; and CitO-H191A, which is irresponsive to citrate and it
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TABLE 3 | Thermodynamic parameters derived from the calorimetric titration of CitO variants with citrate.
Protein KD(µM) N 1H (cal/mol) T1S (cal/mol/deg) 1G (cal/mol)
CitO-wt 1.2 ± 0.2 0.44 6122 47.3 −7983.4
CitO-Q64A 0.77 ± 0.1 0.27 6724 50.5 −8340
CitO-H74A 0.82 ± 0.04 0.33 6500 50.2 −8434.6
CitO-R97A ni* ni* ni* ni* ni*
CitO-F143A 0.44 ± 0.08 0.34 16020 82.9 −8685.7
CitO-H191A ni* ni* ni* ni* ni*
CitO-L214A 1.2 ± 0.2 0.123 5780 46.5 −8070
*no interaction.
has decreased amounts of boundmetal. As expected, the addition
of citrate or metals did not increase the binding of both mutant
proteins to PcitH−CL (data not shown). The pretreatment of
CitO-R97A and CitO-H191A with EDTA showed similar results
(Figures 5E,F).
Mutations in the CitO Citrate Binding
Pocket Reduced In vivo Expression of
PcitCL
The effect of mutations in CitO was determined in vivo by
using a PcitCL fusion to lacZ (pTCV-PcitCL plasmid, Table 1).
E. faecalis JHB1 was transformed with pTCV-PcitCL (Strain
JHB14). Strain JHB14 was subsequently transformed with pCitO
derived plasmids (Table 1), which allowed the constitutive
expression of the wild type or mutant forms of CitO. Strain
JHB14-02 carrying the empty pBM02 plasmid was used as a
negative control (Table 1). The densitometry analysis of CitO
immunoreactive bands (Figure 6B) was used to normalize the
reporter activity.
It was found that in the absence of citrate, strains carrying
CitO-Q64A, CitO-F143A had a two-fold reduction in the β-
galactosidase activity compared to CitO-wt. Strain JHB14-191,
carrying CitO-H191A, showed a four-fold reduction in the
base level activity, while strains JHB14-74, JHB14-97, and
JHB14-214 (carrying CitO-H74A, CitO-R97A, and CitO-L214A,
respectively) showed activity levels similar to the empty plasmid
control. These results are in agreement with the reduced DNA
binding activity found in EMSA.
When LB was supplemented with citrate, the β-galactosidase
activity was induced in the strains containing CitO-wt, CitO-
Q64A, or CitO-F143A (Figure 6). These results are similar to the
in vitro results obtained by EMSA and ITC. In contrast, strains
carrying CitO-H74A, CitO-R97A, CitO-H191, or CitO-L214A
showed a reduced β-galactosidase activity in presence of citrate.
The results obtained in CitO-H74A mutant suggest that
modifications in the HTH domain introduced in CitO-H74A
resulted in a reduced DNA and citrate binding in vivo. These
results contrast the DNA binding with the ITC data, where
citrate binds with similar affinities to CitO-H74A and CitO-
wt. The apparent discrepancy can be explained by the potential
involvement of H74 in signal transduction from the DNA to the
ligand binding domain in CitO, and that its mutation affected the
ability of CitO to transduce the signal between these domains.
Mutations in CitO on residues R97 and H191 showed very
low β-galactosidase activity in presence of citrate. These results
can be explained by the reduced DNA binding capabilities of
thesemutants and the reduced binding affinity of CitO-R97A and
CitO-H191A for citrate observed in vitro. Based on the combined
in vitro and in vivo results, we concluded that residues R97 and
H191 in CitO mediate the binding to citrate.
In contrast to the low basal level activity observed in the CitO-
L214A strain in absence of citrate, the addition of citrate to the
growth media resulted in a large increment in the β-galactosidase
activity (64-fold). These results are similar to those obtained in
EMSA (reduced DNA binding to PcitH−CL) and ITC (similar
affinity for citrate as CitO-wt).
DISCUSSION
CitO is a transcriptional activator of the citrate metabolism
in E. faecalis. It has been classified as a member of the
GntR superfamily and clustered in the FCD family. The main
characteristic of this subgroup of proteins was established based
on the structural features of T. maritima TM0439. In this
transcription factor, one nickel ion and two acetate molecules
were present in the crystal structure of TM0439. Based on these
findings, Zheng et al. (2009) suggested that the majority of
proteins with FCD domains should be metal binding proteins.
Contrary to traditional metal sensing transcription factors, such
as ArsR, MerR, Fur, DtxR, or CodY, in TM0439 the metal is
buried at the bottom of the ligand binding cavity. The buried
location of the metal suggested an important contribution of the
metal center in stabilizing the overall active pocket structure.
However, the role of individual amino acids in the metal or
carboxylic acid binding was not assessed. In order to gain
further insight on the ligand-protein interactions within the
FCD domains, CitO structure was modeled in the automated
mode. The structure of T. maritima TM0439 (PDB 3FMS)
and PDB 3C7J corresponding to a transcriptional regulator
from P. syringae pv. tomato str. DC3000 were retrieved as the
highest scoring templates. In TM0439, the location of two acetate
molecules, one in the N-terminus and another in the C-terminus,
generated uncertainties on which was the biologically relevant
pocket. Although the biological role of the acetate molecules
has not been determined for TM0439, their location proved
instrumental in the identification of the citrate binding pocket
in CitO.
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FIGURE 5 | Metal binding to CitO promotes binding to PcitH−CL in presence of citrate. EMSA were performed using biotin-labeled DNA (1 ng); 0.2µM CitO-wt
(A–D), CitO-R97A, or CitO-H191A (E,F); Me2+ (2mM) in the absence (A,C,E) or presence of 5mM citrate (B,D,F). CitO used for (A) and (B), was incubated in buffer
and then dialyzed, whereas the CitO-wt or mutants shown in (C–F) were incubated with EDTA for 2 h at 4◦C and then dialyzed over night before conducting EMSAs.
Previous molecular data obtained with FadR from E. coli
showed that acyl-CoA binds in the C-terminal domain (Raman
and Dirusso, 1995; Van Aalten et al., 2000, 2001) showed that
upon binding to the acyl-CoA molecule, the protein backbone
undergoes dramatic conformational shifts throughout the main
protein scaffold. This movement, typical of allosteric proteins,
generates a rearrangement of the DNA binding domains. As a
consequence of such movement, the DNA recognition helices
become largely separated, preventing the interaction with the
DNA molecule and consequently derepressing transcription. In
order to discriminate which of the two putative citrate binding
sites were active in CitO we performed site-directed mutagenesis
at both sites. Mutations of CitO residues Q64 and H74 (located
in the N-terminal domain) confirmed that CitO complies with
the GntR paradigm, in which the N-terminal domain is involved
in DNA binding and not in ligand interaction. Interesting,
mutagenesis of residues in the C-terminal part of CitO affected
both DNA and ligand binding.
In the C-terminal FCD domain, the CitO F143 residue was
located in close proximity to the acetate molecule found in
TM0439. The change of F143 to alanine did not affect DNA
binding in the absence of citrate. Surprisingly, a dramatic increase
in DNA binding was observed upon addition of citrate. This in
vitro data suggested that F143 could act as a gate keeper thereby
restricting or modulating access of citrate to its binding pocket.
However, CitO-F143A was less effective to induce PcitCL activity
in vivo. Another interesting result was obtained with a mutant
in residue L214. Although the ligand binding was not affected
in the CitO-L214A mutant in vitro, the mutation appears to
be critical for protein function as evidenced by the very low
transcriptional activation of the β-galactosidase reporter gene in
vivo. Collectively, the results indicate that although some of the
residues that form the ligand binding cavity are not involved
in direct contact with citrate, they may have an important role
in allowing the protein to acquire an optimal conformation for
DNA binding.
Conversely, CitO residues R97 and H191 were found to be
essential for both DNA and ligand binding as determined by ITC,
EMSA, and in in vivo tests, suggesting that those residues are
in direct contact with the citrate molecule. These two residues
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FIGURE 6 | Amino acid substitutions in CitO affect the modulatory
activity of CitO on promoter activity. (A) pBM02 derived plasmids were
used to express constitutively CitO and its variants in a citO deficient strain
harboring pTCV-PcitCL reporter plasmid. Cells were grown in the presence
(gray bars) or absence (black bars) of 17mM citrate, and assayed for
β-galactosidase activity (expressed in arbitrary units, AU) after 6 h of growth.
(B) The quantification of the protein levels by Western blot, using polyclonal
antibodies against CitO, was performed by densitometry in order to calculate
specific β-galactosidase activity. CitO(p) 0.1µg of purified CitO used as a
positive control.
may also be involved in further signal transduction to the N-
terminus, allowing the correct positioning of the HTH domain
on the DNA. In the E. coli biofilm repressor McbR (PDB: 4PF9),
although the ligand was not defined in the structure, the residues
R89 (R97 in CitO), D135 (F143 in CitO), R139 (D147 in CitO),
and D211 (Supplementary Figure S1) were indicated as involved
in ligand binding (Lord et al., 2014). The structural model
constructed for CitO indicated that H191 is part of an Asn147-
His191-His213 triad involved in the coordination of a divalent
cation. Accordingly, stoichiometric amounts of Ni2+ were found
in CitO-wt samples, whereas the CitO-H191A mutant showed a
strong reduction in Ni2+ concentrations. The decreased amount
of metals in CitO-H191A correlated with a reduction on DNA
and ligand binding affinities (Figures 2, 3, Table 3). These results
suggest that the metal is important for protein function and
that the remaining residues of the pocket (Asn147 and His213),
perhaps with the aid of second sphere of coordination, could
still bind Ni2+ but in a less efficient configuration. Furthermore,
when the metal was removed from the CitO-wt, the protein was
unable to sense the presence of the citrate (Figure 5D), indicating
that both citrate and the metal are required for proper protein
function.
The presence of metals in the GntR superfamily of
transcriptional factors was initially reported in the repressor LldR
from Corynebacterium glutamicum (PDB 2DI3) involved in L-
lactate and fructose/glucose utilization. A Zn2+ ion was located
in the structure at the core of the helical bundle with three
coordinating histidine residues (His148, His196, and His218);
however, the biological role of the cation in this protein was
not determined (Gao et al., 2008). The metal binding site is
conserved across other proteins containing the FCD domain,
such as TM0349 (Zheng et al., 2009) and PS5454 from P. syringae
(PDB: 3C7J; Supplementary Figure S1). These residues are also
highly conserved in other sequence homologs of CitO found in
Streptococcusmutants, Streptococcus pyogenes, Lactobacillus casei,
Lactobacillus sakei, and E. faecium that are associated with the
citrate fermentation pathways.
The binding of citrate in complex with a metal seems
widespread in other families of transcription factors. Recently a
citrate-Mg2+ binding pocket was reported for AcnR, a member
of TetR family of transcriptional regulators. AcnR controls the
expression of aconitase in C. glutamicum (Garcia-Nafria et al.,
2013). Contrary to other TetR ligands, the citrate-Mg2+complex
was found in a second binding site distant from the DNA-binding
domain, with a KD of 6mM. The ligand was located with its
apolar carbon atoms pointing to the hydrophobic interior and
the polar atoms facing the outer side of the pocket. In AcnR, the
magnesium ion is coordinated by three oxygens in the citrate,
two water molecules, and the carboxyl oxygens of a glutamic acid
residue (Garcia-Nafria et al., 2013).
In conclusion, previous structure-based evidence suggested
that members of FCD family may act as metal-sensors or that
the metal present in these domains would play a rather structural
role while being required for interaction with other effector
molecules. Based on the evidence presented here, we proposed
that citrate interacts with the buried Ni2+ or Zn2+ molecule
in the C-terminal domain, triggering conformational changes
in CitO that reorient the N-terminal DNA binding domain,
increasing the recognition of its specific DNA target.
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